Objective: A prospective study was carried out to evaluate the role of ultrasonography in the diagnosis of hepatic metastasis and also to preoperative determination of hepatic metastasis and its validity in diagnostic process. 6%, 80.0%, 92.3%, 97.8% and 57.1% respectively. 
Introduction
Hepatic metastases are common in the adult and 20 times more frequent than primary malignancy of liver 1 . The liver is second in prevalence only to regional lymph node as a site of metastatic disease. Approximately 25% to 50% of all patients who die of malignant disease have metastatic disease to the liver at autopsy 1 . A silent primary neoplasm with hepatic metastases is most often found to be a result of pancreatic, stomach or lung carcinoma 2 . Metastases are nearly always multiple. They are more frequently encountered in the right lobe than the left as large mass of the right lobe and its greater blood flow 3 . The primary neoplasm is asymptomatic in about half the patients 4 . However massive destruction of liver substance or direct obstruction to major bile ducts may occur 5 . There is usually rapid liver enlargement with fever, weight loss and jaundice. Peritoneal dissemination frequently results in ascites 4 . Significant advances in cross-sectional imaging modalities like ultrasound now allow not only detection but often non-invasive characterization of focal and diffuse hepatic process. The presence of metastatic disease to the liver is a prima determinate of survival. Over the last decade, there have been tremendous advances in the treatment of metastatic disease of the liver. Liver resection or liver directed therapy is justified to select patients when extrahepatic malignancy is not present and the patients can tolerate therapy 3 .
In patients with suspected metastatic disease, several imaging procedures are used to detect liver metastases. They include ultrasonography (USG), computed tomography (CT), magnetic resonance imaging (MRI), angiography and radio nuclide scanning. In general, however, USG, CT, and MRI are more accurate than angiography or radionuclide scanning. CT is more specific for detection of tumour nodules but because of its less availability, expense and radiation hazards, it is reserved for complicated cases which can not be detected by other modalities. MRI is also specific but more expensive and lack of its availability makes it more difficult to use as primary modality of investigation. Ultrasound is an excellent screening modality for metastatic liver disease because of its relative accuracy, speed, lack of ionizing radiation and availability 6 . It allows not only detection but often non-invasive characterization of focal and diffuse hepatic process. It is also selected as because it can be done repeatedly and rapidly with least expense. When a patient with previously diagnosed malignancy subsequently develops a liver mass, a fine needle aspiration is performed for histopathological confirmation 7 . Ultrasonographic guidance is usually preferred for its simplicity, capability of real time monitoring and flexible needle tract placement 6, 7 . Cytopathological confirmation is also needed for diagnosis of hepatic metastasis 5 . Therefore, the aims of the present study were to correlate ultrasonography and cytopathological findings in hepatic metastases and to determine the sensitivity and specificity of ultrasonography to diagnose hepatic metastases of malignant diseases compared with cytopathological findings. At first all these patients were evaluated by detail history, clinical examination with special emphasis on hepato-biliary sytem. Sonographic examinations were then performed for the evaluation of hepatic metastases. Lobe distribution, multiplicity, echocharacter were evaluated in all the cases. Then fine needle aspiration under ultrasonographic guidance and cytopathological examinations were done and finally were correlated with the sonographic diagnoses.
Methods
Data were collected in a predesigned structured data collection sheet. All the relevant collected 
Results
This study included 52 patients having metastasis in liver diagnosed clinically. They were divided into five age groups. The mean age of the patients was 51.20±11.9 years, ranging from 21 to 69 years. The maximum patients were in >60 years age group and least was in 21 to 29 years age group ( Table-I The validity of ultrasonography were determined by calculating sensitivity, specificity, accuracy, positive predictive value and negative predictive value which were 93.6%, 80.0%, 92.3%, 97.8% and 57.1% respectively ( Table-IX) . 
Discussion
Turkay et al. 8 have shown in their series that the mean age of the patients was 59.7±11.99 years which is slightly higher than that of the present study. Charnsangavej et al. 9 observed that the male female ratio was 3:1 to 4:1 which is in agreement with the present study. Yoshida et al. 10 have shown 85.0% cases of metastases were multiple which is similar with the present study where 92.3% patients were multifocal lesions. This is also similar to the present study. Seheible et al. 11 have shown in a prospective study on 76 patients of hepatic metastasis that echographic pattern was found 18.0% hypoechoic, 37.0% hyperechoic, 28.0% was mixed pattern and 17.0% Bull's eye lesions.
The results of the present study are not similar to the above mentioned study as they also observed the bull's eye lesions.
Turkay et al. 8 observed the sensitivity of ultrasonography in diagnosis of hepatic metastasis which was 85-90%. Almost similar value was obtained by Reinhold et al. 12 . Both investigations support the results of the present study. Dick and Watkinson 1 found the specificity of ultrasonography in diagnosis of hepatic metastasis was 80%. This finding is similar with the present study where specificity was found 80.0%. Turkay et al. 8 further correlated the ultrasonographic findings with post-operative cytopathology specimen. They have observed that the positive predictive value was 97.8% with the histopathology findings. The results of the ultrasonography and cytopathological findings observed in the present study also support the above evidence. Turkay et al. 8 found accuracy 73% to 94 %. Middleton et al. 13 and Fisher et al. 14 also found accuracy of ultrasonography, which were 93.0% and 86.0% respectively. The present study strongly supports the above mentioned studies.
It was also observed that the negative predictive value in the present study was 57.1%. However, there is no known evidence of such study on this regard till date in our country. The results of both ultrasonography and cytopathology in the present series are almost similar. Therefore, the inference can be drawn that ultrasonography is a good modality in the evaluation of hepatic metastasis.
Conclusion
As the cytopathological diagnosis of the present study significantly correlated with the ultrasonographic findings and the validity tests are almost identical as observed by other investigators, it can be concluded that the ultrasonography is a useful diagnostic modality in diagnosis of hepatic metastasis. Hence, ultrasonography has definite value in the diagnosis of hepatic metastasis. Moreover, it is simple, non-invasive, rapid diagnostic tool without having any risk of radiation. 
